Use of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX

Simple item page
dc.contributor.affiliationDivision of Medical Microbiology, Department of Pathology, Stellenbosch University & National Health Laboratory Service, Tygerberg Hospital Francie van Zijl Drive, P.O. Box 241, Cape Town 8000, South Africa.
dc.contributor.affiliationDivision of Virology, School of Pathology, Faculty of Health Sciences, University of the Free State, 205 Nelson Mandela, P.O. Box 339, Bloemfontein 9300, South Africa.
dc.contributor.affiliationAntigen Discovery Inc., 1 Technology Dr., Suite E309, Irvine, CA 92618, USA.
dc.contributor.affiliationWater and Health Research Center, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein 2028, South Africa.
dc.contributor.affiliationEnteric Disease and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka P.O. Box 34681, Zambia.
dc.contributor.affiliationCIDRZ
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.contributor.authorMubanga C
dc.contributor.authorSimuyandi M
dc.contributor.authorMwape K
dc.contributor.authorChibesa K
dc.contributor.authorChisenga C
dc.contributor.authorChilyabanyama ON
dc.contributor.authorRandall A
dc.contributor.authorLiang X
dc.contributor.authorGlashoff RH
dc.contributor.authorChilengi R
dc.date.accessioned2025-05-23T11:40:35Z
dc.date.issued2023-May-04
dc.description.abstractDeveloping a broadly protective vaccine covering most ETEC variants has been elusive. The most clinically advanced candidate yet is an oral inactivated ETEC vaccine (ETVAX
dc.identifier.doi10.3390/vaccines11050939
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10232
dc.sourceVaccines
dc.titleUse of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX

Files

Collections

Published